Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study

Completed

• Conditions: Colorectal Medullary Carcinoma

• Registration Number: NCT03774862
• Lead Sponsor: V.K.V. American Hospital, Istanbul

Brief Summary

Medullary carcinoma (MC) is a rare tumor with solid growth pattern without glandular differentiation and constitute less than 1% of colorectal cancer. Lymph node positivity and distant organ metastasis were reported to be lower than other poorly differentiated adenocarcinomas. Therefore, the diagnosis of MC is pathologically important in terms of follow-up and treatment. MC is commonly localized in the right colon, has a large tumor size, and is mostly diagnosed in the T4 stage. As MC most likely have defects in DNA MMR, the correct pathological diagnosis is important for the postoperative treatment and the prognosis of the patients.

Detailed Description

427 patients with colorectal cancer who were underwent surgery between January 2011 and December 2017, were evaluated retrospectively into 2 groups as MC (n:13) and non-MC (n:414) in terms of demographic characteristics, pathological data and oncological outcomes.

Study Timeline

• Study Start: 2011-01-01
• Primary Completion: 2017-12-31
• Study Completion: 2018-08-01
• Study First Submitted: 2018-09-05
• Status Verified: 2018-12
• Study First Submitted QC: 2018-12-12
• Last Update Submitted: 2018-12-12
• Study First Posted: 2018-12-13
• Last Update Posted: 2018-12-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 13

Inclusion Criteria

• colorectal cancer diagnosis, medullary carcinoma

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival of medullar colorectal carcinomas	7 years